Effects of Anti-IL5 Biological Treatments on Blood IgE Levels in Severe Asthmatic Patients (BIONIGE)
Effects of Anti-IL5 Biological Treatments of Total Blood IgE Levels in Severe Asthmatic Patients: Real-life Retrospective Multicenter Observational Study
Sponsor: Università degli Studi di Ferrara
This observational or N/A phase trial investigates Asthma and Asthma; Eosinophilic and is currently completed. Università degli Studi di Ferrara leads this study, which shows 6 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Dec 2020 — Jan 2021 [monthly]
Completed
Status: Recruiting → Completed
-
Mar 2020 — Dec 2020 [monthly]
Recruiting
▶ Show 1 earlier version
-
Dec 2019 — Mar 2020 [monthly]
Recruiting
First recorded
Oct 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Università degli Studi di Ferrara
For direct contact, visit the study record on ClinicalTrials.gov .